(Q38448131)

English

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

scientific article published on 16 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study (English)

1 reference

Europe PubMed Central

3 September 2017

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

3 September 2017

object named as

Edwin Choy

4

0 references

object named as

Judith Kroep

7

0 references

Piotr Rutkowski

object named as

Piotr Rutkowski

10

0 references

0 references

author name string

Sant Chawla

1

1 reference

Europe PubMed Central

3 September 2017

Robert Henshaw

2

1 reference

Europe PubMed Central

3 September 2017

Leanne Seeger

3

1 reference

Europe PubMed Central

3 September 2017

Stefano Ferrari

6

1 reference

Europe PubMed Central

3 September 2017

Robert Grimer

8

1 reference

Europe PubMed Central

3 September 2017

Peter Reichardt

9

1 reference

Europe PubMed Central

3 September 2017

Scott Schuetze

11

1 reference

Europe PubMed Central

3 September 2017

Keith Skubitz

12

1 reference

Europe PubMed Central

3 September 2017

Arthur Staddon

13

1 reference

Europe PubMed Central

3 September 2017

David Thomas

14

1 reference

Europe PubMed Central

3 September 2017

Yi Qian

15

1 reference

Europe PubMed Central

3 September 2017

Ira Jacobs

16

1 reference

Europe PubMed Central

3 September 2017

publication date

16 July 2013

1 reference

Europe PubMed Central

3 September 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

3 September 2017

14

1 reference

Europe PubMed Central

3 September 2017

9

1 reference

Europe PubMed Central

3 September 2017

901-908

1 reference

Europe PubMed Central

3 September 2017

Giant cell tumor of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Giant-cell tumour of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Giant cell tumour of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign bone tumors--recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human giant cell tumors of bone identification and characterization of cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression in giant-cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970277-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(13)70277-8

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38448131&oldid=2137717203"